Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry represents a **pseudogene** homolog of the transmembrane protein 61 gene. Pseudogenes are DNA sequences that closely resemble functional genes but generally lack protein-coding potential due to disabling mutations such as premature stop codons or frameshifts[1]. Most pseudogenes are not transcribed or translated into functional proteins, though some pseudogenes may influence gene expression of their corresponding "parental" genes or act as regulatory elements through RNA transcripts[1][5][7]. There is no current evidence that the transmembrane protein 61 pseudogene produces any protein or peptide, nor is it involved in known disease mechanisms or considered a therapeutic target. Instead, its principal relevance is as a potential confounder in genetic analyses due to its sequence similarity to TMEM61[5][3]. Summary: - This is **not a functional drug target**, but a pseudogene related to TMEM61. - It does **not code for a transmembrane protein** or function as a receptor, enzyme, or transporter. - It can be a source of confusion in genetic diagnostics but otherwise has no recognized biological, diagnostic, or therapeutic significance[5][1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protein 61 pseudogene.